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Abstract
Purpose Irritable bowel syndrome (IBS) is a functional
bowel disorder with a large negative impact on HRQOL.
The present study examines whether severity of bowel
symptoms is directly related to HRQOL, and/or indirectly,
mediated by the patients’ illness perceptions.
Methods Patients were recruited from an IBS support
group (N = 123), and data were collected online. HRQOL
was measured with the Quality of Life Measure for Persons
with IBS and illness perceptions with the brief Illness
Perception Questionnaire. Mediation models were tested
using the bootstrapping procedure developed by Hayes.
Results Irritable bowel syndrome symptom severity is
directly related to total HRQOL and its subscales; after
entering the mediator variables (i.e. the patients’ illness
perceptions) into the model, this direct association re-
mained only significant for total HRQOL. The relationship
between bowel symptom severity and total HRQOL was
partially mediated by illness perceptions, and its relation-
ship with each of the HRQOL subscales was fully mediated
by the patients’ illness perceptions. Perceived conse-
quences were a mediator of the relationship between bowel
symptom severity, total HRQOL as well as its subscales,
with the exception of Sexuality.
Conclusions Bowel symptom severity not only has a di-
rect relationship with HRQOL, but also an indirect rela-
tionship via the patients’ cognitive and emotional
representations of their illness. In order to better understand
this relationship, future research should not only include
illness perceptions but also assess cognitive and be-
havioural coping responses. Clinicians wanting to improve
patients’ HRQOL should not only focus on the patients’
symptoms, but also on their illness beliefs and coping
responses.
Keywords Irritable bowel syndrome  Illness
perceptions  Disease-specific health-related quality of life 
Symptom severity
Introduction
Irritable bowel syndrome (IBS) is a functional disorder of
the bowel, meaning that it is not characterized by any
structural abnormality, but rather by unexplained pain and
bowel dysfunction [1]. It is diagnosed by the ‘‘Rome III’’
criteria [2]: abdominal discomfort or pain which is (a) re-
lieved by defecation and is (b) associated with a change in
stool frequency and/or consistency and/or (c) associated
with a change in the form or appearance of stool. For a
patient to meet these diagnostic criteria, the symptoms and
associations must have been present at least 3 days per
month for the past 3 months, with the initial onset of
symptoms 3 months or more in the past.
The prevalence of IBS in the general population is high,
ranging, depending upon the study, from 3 to 32 %, with
most studies reporting a prevalence of between 5 and 15 %
[3]. The overall prevalence found in a large survey of
40,000 subjects from different European countries was
11.5 % [4]. A population study conducted in the USA re-
vealed an overall prevalence of 14.1 % [5]. With respect to
gender differences, there is a higher ratio of women who
develop IBS compared to men, ranging from 2:1 to 3:1 [6,
7]. The prevalence of IBS decreases slightly with age [3].
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The socio-economic impact of IBS, based on direct med-
ical costs, decreased work productivity and increased work
absenteeism, is substantial [7, 8]. A recently published
review reported that the direct medical costs associated
with IBS range, depending upon the study, from 1,562$ to
7,547$ per patient per year [9].
Next to a socio-economic impact, IBS also has a con-
siderable impact upon the patients’ personal lives and more
in particular upon their health-related quality of life
(HRQOL). HRQOL encompasses the appraisal of a patient
regarding his or her physical or mental health. This appraisal
depends upon whether patients experience limitations due to
their disease and/or the extent to which their disease inter-
feres with their life and overall functioning [10]. Despite the
fact that IBS is not a life-threatening disease, the syndrome
has a large negative impact on HRQOL, when compared to
healthy controls [7, 8, 11–13]. Several studies have also
shown that HRQOL in IBS is equal to or lower than QOL in
patients suffering from other chronic diseases and conditions
including inflammatory bowel diseases, asthma, migraine,
gastro-esophagal reflux disease, diabetes, dialysis-dependent
end-stage renal disease, breast cancer, heart disease and
severe obesity [10, 14–18].
With respect to the factors influencing HRQOL in IBS,
empirical studies point at severity of bowel symptoms and
psychological factors as the main determinants [8, 14, 19–21].
A study by Naliboff et al. [22] showed that psychological
factors had even a stronger direct effect on HRQOL than
bowel symptoms. In addition, bowel symptoms were found to
also exert an indirect effect on HRQOL, mediated by psy-
chological distress. With respect to the physical and the mental
components of HRQOL, there seems to be a differential pat-
tern of association: severity of bowel symptoms was found to
be a stronger predictor of physical functioning, whereas psy-
chological factors such as anxiety and depression were found
to be stronger predictors of psychological functioning mea-
sured by the SF-12 and SF-36 [23, 24]. This does not come as
a surprise as the psychological functioning dimension of
HRQOL scales such as the SF-12 and SF-36 include items that
could also be part of anxiety and depression scales. It is
therefore important to look at possible psychological sources
of anxiety, depression and HRQOL in IBS patients.
From this perspective, the beliefs that patients hold
about their illness and treatment are potentially important
determinants. Leventhal et al. [25] developed the common
sense model (CSM) classifying these beliefs or illness
perceptions as follows: identity (the label given to and the
symptoms associated with the illness); timeline (beliefs
about duration and course of the illness); consequences
(perception of the illness’s effects on the patient’s daily life
and functioning); causes (the patient’s belief about the
likely cause(s) of the disease) and control (the amount of
control the patient feels he/she has over the illness and the
extent to which he/she considers the medical treatment to
help). A meta-analysis [26] demonstrated a link between
illness perceptions measured according to Leventhal’s
CSM and HRQOL as well as psychological well-being
across a range of different illnesses. More specifically,
perceptions that the illness was controllable were positively
related to psychological well-being, social functioning and
vitality and negatively related to psychological distress.
Perceived consequences, timeline and identity on the other
hand were negatively related to psychological well-being,
social functioning and vitality.
Only a few studies have investigated the relationship
between illness perceptions and HRQOL in IBS. In their
study, Rutter and Rutter [27] found that members of an IBS
patient support network that perceived a lot of conse-
quences of IBS and attributed their symptoms to a psy-
chological rather than a physical cause reported lower
HRQOL and higher anxiety and depression scores. Per-
ceiving little control over the illness and thinking that IBS
would be difficult to cure was associated with both lower
HRQOL and higher depression scores. In another study,
adopting a longitudinal perspective, Rutter and Rutter [28]
found that strong consequence beliefs at baseline predicted
higher anxiety and depression scores at 12-month follow-
up in a population of IBS patients consulting their primary
care physician. A study by Riedl et al. [29] demonstrated
that IBS patients with mainly somatic illness attributions
reported worse physical HRQOL, whereas patients with
mainly internal psychological attributions reported better
physical but worse mental HRQOL.
While the aforementioned studies pointed at a relation-
ship between illness perceptions and HRQOL in IBS, in
each of these studies HRQOL was measured by means of a
generic rather than a disease-specific questionnaire. Generic
measures typically assess HRQOL independent of the
specific characteristics of a particular disease, making them
suitable for comparing HRQOL across diseases. The dis-
advantage of a generic measure is, however, that it is not
condition-specific, and as a consequence, important aspects
related to the impact of a particular disease on HRQOL may
be neglected. For the purpose of the present study, a disease-
specific HRQOL measure was used. This allows us to cap-
ture the patients’ subjective evaluation of HRQOL more
adequately as it specifically addresses the patients’ concerns
and experiences associated with the symptoms of IBS [30].
Previous studies on the relationship between illness
cognitions and HRQOL have not taken the severity of IBS
symptoms into account. A review article on HRQOL in IBS
concluded, however, that ‘‘the severity of the bowel symp-
toms in IBS patients is associated with a corresponding
impact on HRQOL’’ [14, p. 118]. It is therefore important,
when studying the relationship between patients’ cognitions
about their condition and HRQOL, to also include the
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severity of bowel symptoms as a potential determinant of
HRQOL. The study by Naliboff et al. [22], pointing at the
fact that bowel symptom severity has not only a direct effect
on HRQOL, but also an indirect effect, mediated by psy-
chological factors, suggests that a mediation model is an
adequate way to study the association between symptom
severity, cognitive factors (i.e. illness perceptions) and
HRQOL in IBS patients.
For the purpose of the present study, it was hypothesized
that patients’ illness perceptions mediate the impact of
bowel symptom severity on HRQOL. The direction of the
pathways was based upon the core principle/basic tenet of
cognitive behavioural theory, namely that an event or
trigger (i.e. bowel symptoms/pain) sets in motion cognitive
processes (i.e. negative beliefs/illness perceptions), leading
to negative emotional or behavioural consequences (i.e.
poor HRQOL) [31]. This core principle has also been in-
tegrated in explanatory models for medically unexplained
symptoms and syndromes [32].
Research question
The present study examines to what extent severity of
bowel symptoms is directly related to disease-specific
HRQOL in IBS patients, and/or indirectly, mediated by the
patients’ illness perceptions. It is also examined whether
there is a differential pattern of associations between
severity of bowel symptoms, illness perceptions and
HRQOL depending upon the specific (physical, emotional
or social) dimension of HRQOL that is looked at.
Methods
Study design and procedure
Data were collected with an online self-report measure.
Respondents were recruited from an IBS patient support
group by placing an advertisement and an invitation to
participate on the Internet forum and newsletter of the
support group. If patients were interested in participating in
the study, they could log on to the website anonymously.
On the website, a letter containing information on the study
was provided, accompanied by a statement emphasizing
the confidentiality of data collection. Respondents gave
their informed consent by ticking a box before they got
access to the study questionnaire. The study was approved
by the ethical committee of Leiden University.
Participants
One hundred and forty-four subjects filled in the ques-
tionnaire (126 women and 18 men). Subsequently, 21
subjects were excluded from the study because they did not
qualify for an IBS diagnosis according to the Rome III
criteria [2]. The final sample consisted of 123 subjects (108
women and 15 men). Ages ranged from 16 to 61, with a
mean age of 32.43 (SD = 11.82). The female-to-male ratio
in the present study (88 vs. 12 %) is not in accordance with
existing epidemiological data [6, 7]. It is, however, com-
parable to the ratio reported by Rutter and Rutter [27], a
study that also recruited respondents from an IBS network.
Measures
A self-report questionnaire based upon the ‘‘Rome III’’
criteria for IBS was administered to determine whether the
respondents qualified for an IBS diagnosis. The question-
naire contained 16 items, measuring different IBS symp-
toms such as bowel pain, stool frequency and stool
consistency, based upon the Rome II Modular Question-
naire [33] and adapted to fit the newer ‘‘Rome III’’ criteria.
Irritable bowel syndrome symptom severity was mea-
sured with three questions from the irritable bowel severity
scoring system (IBSSS) [34], measuring (a) severity of
abdominal pain (0 = no pain, …, 100 = severe pain),
(b) severity of abdominal distension or bloating (0 = no
distension,…, 100 = severe distension) and (c) number of
days patients experienced pain in the last 10 days. A total
severity score was calculated by adding up the score on (a),
the score on (b) and the number of days (c) multiplied by
10, leading to a possible total score of 300. Francis et al.
[34] examined the reliability and validity of the IBSSS.
The test–retest reliability of the IBSS was good as scores
repeated within 24 h were highly reproducible. The IBSSS
was also found to distinguish well between healthy controls
and patients suffering from IBS, and between patients
clinically diagnosed with mild, moderate and severe IBS,
indicating that the criterion validity of the IBSSS was
good. Finally, the responsiveness (sensitivity) to change
was found to be very good; in patients who became con-
siderably better, the severity score showed a highly sig-
nificant improvement.
Illness perceptions were measured using the Dutch
Language Version of the Brief Illness Perception Ques-
tionnaire (Brief IPQ-DLV) [35] which has been shown to
have acceptable reliability and validity. The Brief IPQ was
shown to have good test–retest reliability over a period of 3
and 6 weeks. The questionnaire also demonstrated to have
good concurrent validity with similar measures and to
adequately predict a number of relevant disease outcomes
such as return to work and HRQOL across different patient
groups [36, 37]. The (single-item) dimensions conse-
quences, timeline, identity, personal control, treatment
control and coherence, and the (two-item) dimension
emotional representation were administered. One open-
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ended question measures the perceived cause of the illness.
Respondents had to note down what they considered to be
the most important cause of their IBS. Subsequently, these
answers were recoded into a dichotomous variable where
1 = a psychological cause (e.g. stress or life events) and
2 = a somatic cause (e.g. heredity or immune deficien-
cies). For the subscales consequences, timeline, identity
and emotional representation, higher scores represent more
negative illness perceptions (e.g. more consequences or a
longer timeline). For the subscales personal control, treat-
ment control and coherence, higher scores represent more
positive illness perceptions (e.g. more personal control or
more treatment control).
Health-related quality of life was assessed by means of
the Dutch version of the Quality of Life Measure for
Persons with IBS consisting of 34 items (IBS-QOL) [38,
39]. The psychometric properties of the IBS-QOL were
demonstrated to be good. The test–retest reliability was
good after a 1-week interval. Internal consistency was
found to be high for overall QOL (a = 0.95), as well as
for all of the subscales (ranging from 0.74 to 0.93) with
the exception of the subscale relationships (a = 0.65).
Criterion validity was good as the questionnaire distin-
guished well between mild, moderate and severe IBS
patients. Convergent validity analyses pointed out that the
IBS-QOL was more closely related to overall well-being
than to physical functioning measures [38]. For the pur-
pose of the present study, the score for the total scale
(a = 0.93) as well as the scores for the following sub-
scales was used: dysphoria (a = 0.90; eight items; e.g. ‘‘I
feel my life is less enjoyable because of my bowel
problems’’.); interference with activity (a = 0.85; seven
items; e.g. ‘‘I feel I get less done because of my bowel
problems’’.); body image (a = 0.65; four items; e.g. ‘‘I
feel fat because of my bowel problems’’.); health worry
(a = 0.37; three items; e.g. ‘‘I feel vulnerable to other
illnesses because of my bowel problems’’.); food avoid-
ance (a = 0.73; three items; e.g. ‘‘I have to watch the
kind of food I eat because of my bowel problems’’.);
social reaction (a = 0.70; three items, e.g. ‘‘I worry that
people think I exaggerate my bowel problems’’.); sexu-
ality (a = 0.85; two items; e.g. ‘‘My bowel problems
reduce my sexual desire’’.); and relationships (a = 0.62;
three items, e.g. ‘‘My bowel problems are affecting my
closest relationships’’.). All items were scored on a
5-point Likert scale, indicating to what extent the re-
spondents could relate to each of the statements: not at
all, slightly, moderately, quite a bit and extremely. Due to
the low Cronbach a scores, the subscales body image,
health worry and relationships were excluded from further
analysis. The summed total and subscale scores were
transformed to a 0–100 scale ranging from 1 (poor
HRQOL) to 100 (excellent HRQOL).
Statistical analysis
Pearson’s correlation coefficients examined univariate as-
sociations between severity of bowel symptoms (indepen-
dent variable), illness perceptions (mediator variables) and
HRQOL (dependent variable), as well as possible multi-
collinearity between the independent variable and the
mediator variables. Independent t tests compared scores on
the different HRQOL subscales between men and women,
patients with a low versus high educational level and pa-
tients reporting a psychological versus somatic cause for
IBS symptoms. Subsequently, six multiple mediation
models were constructed and tested; each of these models
placed illness perceptions as potential mediators between
bowel symptom severity on the one hand and HRQOL
(total score as well as the five subscale scores) on the other.
Multiple mediation analysis was considered to be the most
appropriate analytic strategy as it allows for multiple
indirect effects to be tested simultaneously [40]. As such,
the relative magnitude of the specific indirect effects as-
sociated with each putative mediator (i.e. the illness per-
ceptions) was determined. The mediation models were
tested using the bootstrapping procedure suggested by
Hayes [41]. This method produces an estimate of the
magnitude of each indirect effect, as well as a corre-
sponding confidence interval. An indirect effect is assumed
to be significant at an alpha level of 0.05 if its 95 % con-
fidence interval (CI) does not include zero. A bias-cor-
rected bootstrap CI was calculated, as this is considered to
be the best test in terms of statistical power; on the basis of
a number of simulations, Hayes and Scharkow [42] have
demonstrated that the bias-corrected bootstrap CI is the
most trustworthy test when an indirect effect exists. SPSS
20.0 was used for the descriptive and univariate analyses.
The indirect.sps macro for SPSS [43] was used for all
mediation analyses.
Results
The descriptives for severity of bowel symptoms, the IPQ
dimensions and the HRQOL subscales are shown in
Table 1.
No significant differences were found between men and
women, patients with a higher versus lower educational
level and patients reporting a psychological cause versus a
somatic cause for IBS symptoms on any of the QOL
dimensions.
Age was not significantly related to QOL. Severity of
bowel symptoms was significantly related to both total
HRQOL and each of the subscales. With respect to illness
perceptions, only the Brief IPQ dimensions measuring
consequences, identity and emotional representation were
1848 Qual Life Res (2015) 24:1845–1856
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significantly related to HRQOL. None of the Pearson’s
correlations between the independent and the mediator
variables exceeded the 0.80 multicollinearity threshold
suggested by field [44]. The correlation coefficients are
reported in Table 2.
Based on the results of the univariate analyses, only the
Brief IPQ dimensions measuring consequences, identity
and emotional representation were entered as potential
mediators in the mediation models with severity of bowel
symptoms as the independent variable and HRQOL as the
dependent variable (Fig. 1).
Mediation analyses
To answer the question whether the severity of bowel symp-
toms is directly and/or an indirectly related to HRQOL, me-
diated by the patient’s illness perceptions, we first checked the
results for thedirect association between symptom severity and
HRQOL. IBS symptom severity was directly related to total
HRQOL and each of the subscales, but after entering the me-
diator variables into the model, this direct relationship only
remained significant (p\ 0.05) for total HRQOL.
To explore the potential indirect association between
IBS symptom severity and QOL, we first examined the
relationships between the independent variable, severity of
bowel symptoms, and the mediating variables conse-
quences, identity and emotional representation of the Brief
IPQ (a paths); the associations between the independent
variable and each of the mediating variables were sig-
nificant at the 0.01 level (Table 3).
With respect to the association between the mediators and
the dependent variable HRQOL (b paths), a significant re-
lationship was found between the IPQ dimension conse-
quences and total HRQOL, as well as the HRQOL subscales
dysphoria, interference with activity, food avoidance and
social reaction. The second mediator, identity, was only
significantly related to the HRQOL subscale sexuality,
whereas the third mediator variable, emotional representa-
tion, was significantly related to total HRQOL, and the
dysphoria and social reaction subscales.
Finally, the analysis of the indirect relationship be-
tween IBS symptom severity and HRQOL revealed that
bowel symptom severity was indirectly related to total
HRQOL as well as the subscales dysphoria and social
reaction (a 9 b paths), mediated by the IPQ dimensions
consequences and emotional representation. A significant
indirect relationship was found between symptom severity
and the subscales interference with activity and food
avoidance, mediated only by the IPQ dimension conse-
quences. The relationship between symptom severity and
the subscale sexuality was only mediated by identity. The
results of the mediation analyses are presented in Table 3
and Fig. 2.
As a whole, each of the models was significant, ex-
plaining 60 % of the variance in total HRQOL (Adj.
R2 = 0.59, p\ 0.001), 64 % of the variance in the sub-
scale dysphoria (Adj. R2 = 0.63, p\ 0.001), 36 % of the
variance in the subscale interference with activity (Adj.
R2 = 0.34, p\ 0.001), 16 % of the variance in the sub-
scale food avoidance (Adj. R2 = 0.13, p = 0.001), 33 %
of the variance in the subscale social reaction (Adj.
R2 = 0.31, p\ 0.001) and 21 % of the variance in the
subscale sexuality (Adj. R2 = 0.18, p\ 0.001).
Discussion
In this study, we examined to what extent severity of bowel
symptoms is directly related to HRQOL and/or indirectly,
mediated by the patients’ illness perceptions.
Table 1 Descriptives for
severity of bowel symptoms,
illness perceptions and health-
related quality of life
a Values are mean ± SD unless
otherwise indicated
Variable Descriptivesa
Frequency and severity of bowel symptoms (0–300) 168.02 ± 68.67
IPQ consequences (0–10) 6.81 ± 2.18
IPQ timeline (0–10) 9.08 ± 1.30
IPQ identity (0–10) 7.73 ± 1.61
IPQ personal control (0–10) 3.72 ± 2.16
IPQ treatment control (0–10) 4.73 ± 2.52
IPQ coherence (0–10) 6.03 ± 2.33
IPQ emotional representation (0–20) 13.04 ± 4.13
Total QOL (0–100) 61.02 ± 17.22
QOL dysphoria (0–100) 57.04 ± 22.92
QOL interference with activity (0–100) 62.54 ± 23.59
QOL food avoidance (0–100) 47.90 ± 25.13
QOL social reaction (0–100) 61.86 ± 24.33
QOL sexuality (0–100) 70.33 ± 27.09
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Our main findings were: (1) severity of bowel symptoms
is directly related to total HRQOL and its dimensions; (2)
the relationship between bowel symptom severity and total
HRQOL is partially mediated by illness perceptions,
whereas its relationship with each of the separate dimen-
sions of HRQOL is fully mediated by illness perceptions;
(3) the total model, including both the independent variable
disease severity and the mediators explained a very high
percentage (60 %) of the variance in total HRQOL; (4)
perceived consequences of IBS are a mediator of the re-
lationship between bowel symptom severity and total
HRQOL as well as all of its subscales, except one (the
subscale sexuality); (5) neither perceived cause nor the
control-related dimensions of the brief Illness Perception
Questionnaire are significantly related to bowel symptom
severity or HRQOL.
The existence of a direct relationship between bowel
symptom severity and HRQOL is in accordance with pre-
vious studies [22–24]. The correlation coefficients, how-
ever, also indicate that this direct relationship is not as
strong as the relationship between the psychological factors
(in this case the patients’ illness perceptions) and HRQOL,
which was also found by Naliboff et al. [22]. The me-
diation analyses that we conducted demonstrated that the
relationship between bowel symptom severity and HRQOL
is partially (in the case of total HRQOL) to fully (in the
case of each of the dimensions of HRQOL) mediated by
illness perceptions. This result somewhat fits the findings
of Naliboff et al. [22], who demonstrated in a population of
IBS patients that symptom severity was not only directly,
but also indirectly related to HRQOL, mediated by psy-
chological factors. The major difference between Nalib-
off’s study and ours is that we looked into the patients’
illness perceptions as a mediator, whereas Naliboff con-
sidered psychological distress as the potential mediating
factor.
Previous studies pointed at the existence of a differential
relationship between symptom severity, psychological
factors and HRQOL [23, 24]. In particular, these studies
demonstrated that IBS symptoms and pain were more
strongly related to the physical dimension of HRQOL,
whereas depression, somatic distress and anxiety were
more strongly related to the psychological dimension of
HRQOL. These findings are partially supported by the
present study. Our results indicate that the emotional rep-
resentation of illness mediates the relationship of symptom
severity with the HRQOL subscale dysphoria, a disease-
specific measure of depression, and, as such, a psycho-
logical dimension of HRQOL. In addition, emotional rep-
resentation also mediates the association between symptom
severity and the subscale social reaction, a social dimen-
sion of HRQOL that was not considered in the studies by
Rey et al. [23] and Koloski et al. [24]. ‘‘Consequences’’,
one of the illness perceptions that underlies the cognitive
representation of illness, however, mediates the relation-
ship between symptom severity and the subscales dys-
phoria, interference with activity, food avoidance and
social reaction, or in other words, psychological, physical
as well as social aspects of HRQOL. This latter finding
does not support the idea that there is a distinct pattern of
associations between symptom severity, illness perceptions
and HRQOL depending upon the specific dimension of
HRQOL that is looked at. It rather points at the central role
of the cognitive illness representation ‘‘consequences’’. As
‘‘consequences’’ have been measured with a single item in
the present study, it remains unclear which perceived
consequences contribute to this finding. A number of
(qualitative) studies, evaluating (the impact of) IBS
‘‘through the patients’ eyes’’, [45–47] point at the fact that
IBS causes multiple aspects of life to be disrupted: physical
functioning, social functioning/activities/relationships/
roles as well as psychological well-being. With respect to
psychological well-being, patients mention feeling stig-
matized by the presence of a condition for which no clear
somatic cause can be found and feeling embarrassed be-
cause of the symptoms (e.g. abdominal bloating or diar-
rhoea). In addition, a number of misconceptions regarding
the consequences of IBS are reported (e.g. the belief that
IBS could lead to colitis or cancer), causing anxiety and
fear in patients. Next to that, the impact IBS has on phy-
sical functioning and social activities constitutes a threat to
patients’ identity and self-image and may ultimately be
responsible for feelings of depression. Uncertainty about




















Fig. 1 Mediation models that
were tested. Note a1–3 effect of
independent variable on
mediators, b1–3 effect of
mediators on dependent
variables, IBSS irritable bowel
symptom severity, HRQol
health-related quality of life
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triggering symptom flare-ups and the unpredictability of
symptoms may be factors underlying the disruption of
patients’ lives.
The study by Rutter and Rutter [27] reported a similar
relation between consequences and HRQOL but also found
that attributing IBS to a psychological rather than a phy-
sical cause was associated with poorer HRQOL. Riedl et al.
[29] reported that psychological illness attributions were
associated with worse mental QOL, but better physical
QOL, whereas somatic illness attributions were related to
worse physical QOL. In our study, patients who favoured a
psychological cause of IBS did not differ from patients
who favoured a somatic cause on any of the dimensions of
HRQOL. Differences in the way perceived cause of
IBS was measured may be responsible for this. In their
study, Riedl et al. [29] measured the patients’ illness at-
tributions making use of two different questionnaires, one
questionnaire to measure the dimensions ‘‘intrapsychic
causes’’, ‘‘social causes’’ and ‘‘interpersonal causes’’, and
one questionnaire to measure ‘‘physiological causes’’; for
each of these dimensions, total scores were calculated.
Rutter and Rutter [27] used the ‘‘cause’’ item of the illness
perception questionnaire [48], consisting of ten items; on
the basis of a principal component analysis, two compo-
nents were retained, one measuring internal psychological
causes and one measuring external somatic causes. In
contrast, the patients participating in our study answered an
open-ended question, asking them to note down what they
considered to be the most important cause of their IBS. The
answers to this question were then recoded into a di-
chotomous variable (psychological vs. somatic causes).
These clearly distinct approaches may be responsible for
the difference in results.
Rutter and Rutter [27] concluded that weaker control
beliefs were associated with lower HRQOL. Contrary to
this finding, in our study, neither personal control nor
treatment control was related to any of the dimensions of
HRQOL. The way the control dimension was measured
may at least be partly responsible for the differences found.
In their study, Rutter and Rutter [27] used the cure/control
dimension of the original IPQ [48], consisting of six items
and resulting in a total score, ranging from 6 (min) to 30
(max). As such, no distinction is made between personal
and treatment control in the Rutter and Rutter study,
Table 3 Summary of Mediation Analyses
Independent variable (IV) a paths








Indirect effect an 9 bn 95 % Bootstrap
CI of indirect effect
IBS symptom severity a1 = 0.008** IPQ-C b1 = -3.539*** QOL-T a1 9 b1 = -0.030** -0.054, -0.008
a
IBS symptom severity a2 = 0.011*** IPQ-ER b2 = -2.667*** QOL-T a2 9 b2 = -0.030*** -0.052, -0.015
a
IBS symptom severity a3 = 0.011*** IPQ-I b3 = -0.575 QOL-T a3 9 b3 = -0.006 -0.024, 0.010
IBS symptom severity a1 = 0.008** IPQ-C b1 = -4.635*** QOL-D a1 9 b1 = -0.039** -0.074, -0.010
a
IBS symptom severity a2 = 0.011*** IPQ-ER b2 = -4.558*** QOL-D a2 9 b2 = -0.052*** -0.084, -0.026
a
IBS symptom severity a3 = 0.011*** IPQ-I b3 = -0.709 QOL-D a3 9 b3 = -0.008 -0.033, 0.014
IBS symptom severity a1 = 0.008** IPQ-C b1 = -5.442*** QOL-IA a1 9 b1 = -0.046** -0.088, -0.013
a
IBS symptom severity a2 = 0.011*** IPQ-ER b2 = -1.327 QOL-IA a2 9 b2 = -0.015 -0.042, 0.005
IBS symptom severity a3 = 0.011*** IPQ-I b3 = -0.032 QOL-IA a3 9 b3 = -0.000 -0.032, 0.028
IBS symptom severity a1 = 0.008** IPQ-C b1 = -3.695** QOL-FA a1 9 b1 = -0.031* -0.072, -0.007
a
IBS symptom severity a2 = 0.011*** IPQ-ER b2 = -1.705 QOL-FA a2 9 b2 = -0.019 -0.057, 0.006
IBS symptom severity a3 = 0.011*** IPQ-I b3 = 0.730 QOL-FA a3 9 b3 = 0.008 -0.025, 0.045
IBS symptom severity a1 = 0.008** IPQ-C b1 = -4.495*** QOL-SR a1 9 b1 = -0.038* -0.080, -0.010
a
IBS symptom severity a2 = 0.011*** IPQ-ER b2 = -2.876** QOL-SR a2 9 b2 = -0.033* -0.063, -0.010
a
IBS symptom severity a3 = 0.011*** IPQ-I b3 = 1.177 QOL-SR a3 9 b3 = 0.013 -0.022, 0.049
IBS symptom severity a1 = 0.008** IPQ-C b1 = -2.557 QOL-S a1 9 b1 = -0.022 -0.059, -0.001
a
IBS symptom severity a2 = 0.011*** IPQ-ER b2 = -0.504 QOL-S a2 9 b2 = -0.006 -0.039, 0.024
IBS symptom severity a3 = 0.011*** IPQ-I b3 = -4.692* QOL-S a3 9 b3 = -0.050* -0.102, -0.013
a
Confidence intervals (CI) presented are bias corrected and accelerated, and based on 5,000 bootstrap re-samples
IPQ brief illness perception questionnaire, IPQ-C IPQ consequences, IPQ-T IPQ timeline, IPQ-I IPQ identity, IPQ-PC CIPQ personal control,
IPQ-TC IPQ treatment control, IPQ-CO IPQ coherence, IPQ-ER IPQ emotional representation, QOL quality of life measure for persons with
irritable bowel syndrome, QOL-T total QOL, QOL-D QOL dysphoria, QOL-IA QOL interference with activity, QOL-FA QOL food avoidance,
QOL-SR QOL social reaction, QOL-S QOL sexuality
a 95 % CI does not include zero
*p\ 0.05; **p\ 0.01; ***p\ 0.001
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whereas in our study, two separate one-item scores are
used, each of them ranging from 0 to 10.
This study has several strengths including the use of a
validated disease-specific measure, the IBS-QOL [38, 39],
to assess HRQOL. As symptom severity and illness per-
ceptions are disease-specific constructs, it is important to
also measure the outcome on a disease-specific level. The
diagnosis of IBS was made using the Rome III criteria [2],
and validated measures were used to assess bowel symp-
tom severity [34] as well as the patients’ cognitive and
emotional perceptions of the illness [36]. Furthermore, this
study is also the first one to examine whether the rela-
tionship between bowel symptom severity and HRQOL is
mediated by the patients’ illness perceptions. The study
has, however, also some limitations. First, the study has a
cross-sectional design and therefore does not allow for
clear-cut conclusions regarding the direction of the rela-
tionships that were found. Based upon the basic tenet of
cognitive behavioural theory, it was hypothesized that a
trigger (bowel symptoms) activates cognitive processes
(illness perceptions), which in turn has an impact upon
emotional and behavioural factors (HRQOL). It is, how-
ever, also feasible that poor functioning (HRQOL) leads to
more negative illness perceptions, which in turn influences
symptom severity. Future studies should therefore adopt a
longitudinal perspective to evaluate whether illness per-
ceptions mediate the impact of IBS symptom severity on
HRQOL, measured at a later time point, or whether the
relationship is bidirectional. Second, in the present study,
mediation models were constructed and tested for each of
the six dependent variables separately. As the number of
subjects available for the analyses was rather small com-
pared to the number of models and pathways tested, this
may have led to a type I error, and as such possibly to an
elevation of false positives. Based on the results of our
exploratory analyses into the mediators of the relationship
between bowel symptom severity and HRQOL, future re-
search should focus on constructing more parsimonious
models, making use of SEM. Third, to limit participant
burden, illness perceptions were measured with the Brief
IPQ, consisting of six single-item scales and one two-item
scale. As a consequence, two of the putative mediators in
the mediation models are represented by a single-item
measure (i.e. consequences and identity). With respect to
this, Broadbent et al. [36] found that the correlation coef-
ficients between the single-item scales of the Brief IPQ and
the multi-item scales of the IPQ-R were highly significant
(p\ 0.001), suggesting that the single-item scales suffi-
ciently capture the conceptual domain of each of the illness
perceptions measured by the IPQ-R [49]. Nevertheless,
within the psychometric literature, single-item measures
have been criticized for their lack of precision, because
they tend to categorize people in a relatively small number






    1.Total HRQoL 
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    3.Interference with activity 
   4.Food avoidance 
   5.Social reaction 
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.008** (a1) 
-.106*** (c) / -.040* (c’) 
0.011*** (a3) 
-3.539*** (b1) 









Fig. 2 Direct and indirect effects of irritable bowel syndrome
symptom severity (IBSS) on health-related quality of life (HRQOL;
total and subscales) through the illness perceptions ‘‘consequences’’,
‘‘emotional representation’’ and ‘‘identity’’. Note. a1–3 effect of
independent variable on mediators, b1–3 effect of mediators on
dependent variables, c total effect of independent variable on
dependent variable; c’ = direct effect of independent variable on
dependent variable after the effect of the mediators was taken into
account. Only statistically significant associations are depicted.
* p\ 0.05, ** p\ 0.01, *** p\ 0.001
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measuring illness perceptions by means of its multi-item
counterpart, the IPQ-R [49]. Fourth, due to their low in-
ternal consistency, three subscales of the IBS-QOL (body
image, health worry and relationships) have been excluded
from the statistical analyses. As a consequence, we did not
explore to what extent patients’ illness perceptions (par-
tially) mediate the relationship between symptom severity
and these three HRQOL subscales. Fifth, no data on illness
duration, time since diagnosis or specific treatment fol-
lowed by the patients were available to us. As these vari-
ables may have an impact on the way patients perceive
their condition, this dimension should be taken into account
in future research on the relationship between symptom
severity, illness perceptions and HRQOL. Finally, this
study was conducted in members of an IBS patient support
group, which may reduce the generalizability of the results.
The main finding of the present study is that, in addition
to a direct relationship, symptom severity also has an
indirect relationship with HRQOL, via the cognitive and
emotional representations patients have of their illness.
Perceived consequences, emotional representation and to a
lesser extent identity were found to be a mediator of total
HRQOL and some of its subscales. There is, however, an
important theoretical concern about this finding, a concern
that also applies to other studies that explored the rela-
tionship between disease severity, illness perceptions and
HRQOL. There is clearly a conceptual overlap between
specific illness perceptions such as (a) identity and disease
severity if the disease severity measure is based on patient
reports and (b) consequences and emotional representation
on the one hand and physical and psychological or emo-
tional aspects of quality of life scales on the other hand.
Such overlap makes it difficult to identify a clear cause–
effect relationship between these concepts, since the dis-
ease severity measure may be influenced by identity per-
ceptions, while beliefs about consequences and emotional
representation may be a cause as well as a consequence of
poor HRQOL and functioning. For future research, it is
therefore advisable to also include measures that assess
possible cognitive and behavioural coping responses that
result from these perceptions but are conceptually less
contaminated such as catastrophizing, rumination, gener-
alization (cognitive responses) or limiting behaviour and
symptom management (behavioural responses). This would
allow clinicians wanting to improve the patient’s quality of
life to focus not only on negative illness perceptions but
also on dysfunctional coping patterns. In their 2012 review,
Petrie and Weinman [51] discussed the central role of ill-
ness perceptions as a determinant of patient coping and
patient-related outcomes and pointed out that interventions,
that focus on changing patients’ illness perceptions, are an
emerging field within health psychology. With respect to
IBS, there is increasing evidence for the efficacy of
cognitive behaviour therapy (CBT), a psychological treat-
ment that focusses both on identifying, challenging and
changing negative dysfunctional thoughts about IBS
(symptoms) and on behavioural coping strategies [52]. A
recent study [53] explored cognitive, emotional and be-
havioural mediators of treatment effects following a brief
CBT intervention for IBS. It was demonstrated that cog-
nitive factors, i.e. illness perceptions (measured with the
Brief IPQ) mediated treatment effects. A limitation of this
study [53] is, however, that a sum score was calculated
from the Brief IPQ and entered into the mediation model.
As a consequence, it remains unclear which specific illness
perceptions are the most important mediators of treatment
effects. In addition, the relation between specific illness
perceptions (such as consequences and emotional repre-
sentation) and behavioural responses was not explored.
Future cognitive-based intervention studies in IBS should
examine this further.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
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